Primary treatment of stage IV gestational trophoblastic neoplasia with floxuridine, dactinomycin, etoposide and vincristine (FAEV): A report based on our 10-year clinical experiences
详细信息 查看全文
- 作者：Junjun Yang yangjunjun@pumch.cn" class="auth_mail" title="E-mail the corresponding author ; Yang Xiang ; xiangy@pumch.cn" class="auth_mail" title="E-mail the corresponding author ; xiangyang65@pumch.cn" class="auth_mail" title="E-mail the corresponding author ; Xirun Wan WanXR@pumch.cn" class="auth_mail" title="E-mail the corresponding author ; Fengzhi Feng fengfz1969@sina.com" class="auth_mail" title="E-mail the corresponding author ; Tong Ren 13911202899@163.com" class="auth_mail" title="E-mail the corresponding author
- 关键词：FAEV ; Efficacy ; Toxicity ; Stage IV ; GTN
- 刊名：Gynecologic Oncology
- 出版年：2016
- 出版时间：October 2016
- 年：2016
- 卷：143
- 期：1
- 页码：68-72
- 全文大小：240 K
文摘
- •
Using FAEV chemotherapy as primary treatment for stage IV GTN patients achieved excellent results;
- •
FAEV has a low rate of toxicity, and patients treated with FAEV showed good reproductive outcomes;
- •
FAEV drug-resistant patients could still have chances to achieve CR by being further treated with other chemothearpy.